Managing symptoms for cancer survivors and their caregivers
Need-based Adaptive Symptom Management to Address Social Determinants of Health at Individual, Interpersonal, and Community Levels
This study is testing whether a special handbook and weekly phone support can help cancer survivors and their caregivers manage their symptoms better after treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Arizona Academic / other |
| Locations | 2 sites (Kingman, Arizona and 1 other locations) |
| Trial ID | NCT05360498 on ClinicalTrials.gov |
What this trial studies
This clinical trial focuses on improving the health care and psychosocial needs of cancer survivors and their informal caregivers during the post-treatment period. It involves a randomized control design with at least 106 participants who are either completing or have recently completed cancer treatment. Participants will be assigned to either an intervention group receiving a Symptom Management and Survivorship Handbook along with weekly phone calls, or an attention control group receiving a brochure and similar calls. The study aims to assess symptom distress and provide tailored support to both survivors and caregivers based on their needs.
Who should consider this trial
Good fit: Ideal candidates include cancer survivors aged 18 or older who are within 4 weeks of completing treatment or within 2 years of having completed treatment, along with their informal caregivers.
Not a fit: Patients currently receiving counseling or psychotherapy, or those with a diagnosis of a psychotic disorder may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for cancer survivors and their caregivers by providing effective symptom management and support.
How similar studies have performed: Other studies have shown success with similar psychosocial interventions for cancer survivors, indicating potential for positive outcomes in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria for the survivors: 1. age 18 or older 2. within 4 weeks of completing or within 2 years of having completed cancer treatment with curative intent 3. able to perform basic activities of daily living 4. cognitively oriented to time, place, and person (recruiter determined) 5. able to speak and understand English or Spanish 6. access to a telephone 7. has a caregiver who can be any relationship role (e.g., spouse, sibling, parent, friend) who can participate with them. Inclusion criteria for the caregivers: 1. age 18 or older 2. able to speak and understand English or Spanish 3. telephone access 4. not currently receiving counseling and/or psychotherapy 5. not currently treated for cancer Exclusion criteria for the survivors: 1. Less than 18 years of age 2. Diagnosis of psychotic disorder 3. Nursing home resident 4. Bedridden 5. Currently receiving counseling and/or psychotherapy Exclusion criteria for caregiver: 1. Less than 18 years of age 2. Currently treated for cancer to preserve the distinguishability of "survivor" and "caregiver" 3. Currently receiving counseling and/or psychotherapy
Where this trial is running
Kingman, Arizona and 1 other locations
- KRMC WL Nugent Cancer Center — Kingman, Arizona, United States (Not_yet_recruiting)
- University of Arizona — Tucson, Arizona, United States (Recruiting)
Study contacts
- Principal investigator: Chris Segrin, Ph.D. — University of Arizona
- Study coordinator: Molly Hadeed, MPA
- Email: mcbarry@arizona.edu
- Phone: 520-626-0583
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.